Terumo Corp
TSE:4543
Intrinsic Value
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. [ Read More ]
The intrinsic value of one Terumo Corp stock under the Base Case scenario is 1 975.04 JPY. Compared to the current market price of 2 597.5 JPY, Terumo Corp is Overvalued by 24%.
Valuation Backtest
Terumo Corp
Run backtest to discover the historical profit from buying and selling Terumo Corp stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Terumo Corp
Current Assets | 669B |
Cash & Short-Term Investments | 181.4B |
Receivables | 181.8B |
Other Current Assets | 305.8B |
Non-Current Assets | 1T |
Long-Term Investments | 29.4B |
PP&E | 389.5B |
Intangibles | 558.8B |
Other Non-Current Assets | 44.9B |
Current Liabilities | 351.2B |
Accounts Payable | 87.3B |
Accrued Liabilities | 19.9B |
Other Current Liabilities | 244B |
Non-Current Liabilities | 124.4B |
Long-Term Debt | 75B |
Other Non-Current Liabilities | 49.4B |
Earnings Waterfall
Terumo Corp
Revenue
|
885.2B
JPY
|
Cost of Revenue
|
-429.5B
JPY
|
Gross Profit
|
455.7B
JPY
|
Operating Expenses
|
-324.5B
JPY
|
Operating Income
|
131.2B
JPY
|
Other Expenses
|
-32.1B
JPY
|
Net Income
|
99B
JPY
|
Free Cash Flow Analysis
Terumo Corp
Profitability Score
Profitability Due Diligence
Terumo Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Terumo Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Terumo Corp's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Score
Terumo Corp's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Terumo Corp
According to Wall Street analysts, the average 1-year price target for Terumo Corp is 3 003.9 JPY with a low forecast of 2 474.5 JPY and a high forecast of 3 727.5 JPY.
Shareholder Return
Price
Terumo Corp
Average Annual Return | 5.03% |
Standard Deviation of Annual Returns | 20.51% |
Max Drawdown | -15% |
Market Capitalization | 3.9T JPY |
Shares Outstanding | 1 488 423 600 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 26,482 full-time employees. The firm operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The segment is also engaged in the manufacture and sale of healthcare related products. The Blood System Company segment is engaged in the manufacture and sale of blood transfusion-related products.
Contact
IPO
Employees
Officers
The intrinsic value of one Terumo Corp stock under the Base Case scenario is 1 975.04 JPY.
Compared to the current market price of 2 597.5 JPY, Terumo Corp is Overvalued by 24%.